Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
about
Molecular properties of bacterial multidrug transportersAntibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolutionBiological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.Sparfloxacin resistance in clinical isolates of Streptococcus pneumoniae: involvement of multiple mutations in gyrA and parC genesDrift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniaeIdentification and characterization of the Chlamydia trachomatis L2 S-adenosylmethionine transporterMolecular detection of antimicrobial resistanceParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae.Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.Accumulation of norfloxacin by Bacteroides fragilis.New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolones.Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteriaNonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B Streptococcus from South KoreaATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniaeClinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.Energy metabolism and drug efflux in Mycobacterium tuberculosisIdentification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae.Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine.Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones.Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux.In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniaeExpression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniaeEvidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae.PCR-oligonucleotide ligation assay for detection of point mutations associated with quinolone resistance in Streptococcus pneumoniae.In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism.Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae.Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
P2860
Q28139376-5A69E124-A426-4C8E-A863-DCE83B25BB42Q28484201-B7A51796-C0F9-44EF-AFD2-BA4129F3CDF5Q30251593-C8CB4262-498E-4EB8-BE96-DF7856B1CA33Q30784091-5B90039F-DA72-405D-9D37-49BE5FEB6A16Q33594174-6A8F8A9E-F3D2-4D97-B5A9-E6909536D77DQ33694946-D40A18FD-D0D2-4591-9DDB-938FE9CFD3AFQ33695625-FE0A2932-517B-49EA-8A77-6A4364A32888Q33701409-1F03A15D-BFE9-40BE-A305-1E303806A21AQ33715260-E861C32B-D7A6-413E-94A0-653D4F861E69Q33894423-338DFADF-28A3-47F7-8598-C5B6EE88D5F6Q33975793-4D069557-0052-42D1-98FA-9CAD2B2964E4Q33976037-43988444-8EB6-49AE-80B1-60740CCF5616Q33976517-D318BCAD-873C-422D-ACF0-A2C7D39380D2Q33980313-EAE73AE6-992A-4741-8C52-198E8C9465B2Q33980437-6D658A4E-D76E-4D69-AA5F-FCC96E5DB850Q33981750-A79705FE-894A-41E6-97E9-140B1FCB6D60Q33982211-9BCD7C9B-9BF7-4563-8661-C0BC3D1FE864Q34035762-BB80EF71-A5CD-4918-9F35-8200BC517C55Q34352053-B91085C4-70CF-4E8B-BED3-44E4A6B248C5Q34648805-62739095-DEC0-4E8D-8A6F-510280C38E8EQ36474350-E52AE460-417B-461F-9B9B-15B66E48020FQ36538683-3C70D04C-8BE0-4FAC-B845-4D72F204F646Q37712986-45F5071A-BD52-4726-98CF-FD426DD0EA6EQ39469655-F5B6B878-7A2E-4B20-ADEF-EBB94B119A86Q39470683-ADB88C05-1C5B-4C6E-BC10-40CDF366F2B6Q39471518-CDC35B0E-22BC-42E9-B459-FAA0EC48B64FQ39472017-52FDBD94-C5DC-40F3-9C51-30E654479FE0Q39473327-8E155042-7A7D-4202-B13B-2624F0345F93Q39476686-91EB5174-6F1F-4CFF-88F4-D97090976F54Q39559460-3DF7130C-70E0-4D0A-9129-02DF3CA5DAFEQ39652363-8DF9B93F-EB5C-45D0-86EA-85E73BCF8DDCQ39652951-11190840-917F-4673-A8E4-F0C2FF12C4DFQ39653033-D63C0F41-51CD-423B-A649-4BC62C24F3CBQ39653038-E4FFB60A-379F-4278-9FDB-2B67756AC64FQ39743304-CC1798D2-E901-4C47-BB7F-7DEEEC7B9C66Q40130516-9DD2B6F1-F727-4B7D-A032-62EFA711F5D3Q40621873-39A248CA-D048-4EC5-AAE6-91D0133EACA0Q42041266-24B85A36-36CD-4B38-82A8-D595D525D510Q42273994-AD5CC253-3423-4C95-B32E-2D55ED844B46Q42844652-E9AD8A7E-CB37-42D3-B33D-CBA2B6FA57C6
P2860
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
@ast
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
@en
type
label
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
@ast
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
@en
prefLabel
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
@ast
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
@en
P2093
P2860
P356
P1476
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae
@en
P2093
P2860
P304
P356
10.1128/AAC.41.9.1973
P407
P577
1997-09-01T00:00:00Z